Rasdegafusp alfa Uses, Dosage, Side Effects and more

Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer).

Trade Name Rasdegafusp alfa
Generic Rasdegafusp alfa
Rasdegafusp alfa Other Names Rasdegafusp alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share